ArticleOncoTargets and therapy2019

Insulin-like growth factor-1, metabolic abnormalities, and pathological complete remission rate in HER2-positive breast cancer patients receiving neoadjuvant therapy.

Yi-Wei Tong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.